Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jagdeesh Ullal"'
Publikováno v:
J Diabetes Sci Technol
Autor:
Jagdeesh Ullal, Joseph Aloi
Publikováno v:
Current diabetes reports. 19(11)
The goal of this review is to summarize information about insulin dosing software and calculators used as computerized decision support systems or electronic glucose management systems (eGMS). These are used for hospitalized, insulin-treated patients
Autor:
Rajan Lamichhane, Aaron Nelson, John E. Brush, Elias S. Siraj, Brynn E. Sheehan, Jagdeesh Ullal
Publikováno v:
Diabetes. 68
Background: Most studies demonstrating the benefit of perioperative glycemic control in patients undergoing CABG have primarily focused on inpatient glucose management protocols only. Our study evaluated outcomes before and after implementation of an
Publikováno v:
Diabetes Technology & Therapeutics. 18:100-103
Efforts at improving quality metrics in diabetes focus on minimizing adverse events and avoiding re-admissions to the hospital. Our experience with Glucommander™ (Glytec, Greenville, SC), a cloud-based insulin management software system, suggested
Publikováno v:
Journal of Diabetes and its Complications. 21:63-67
A 57-year-old Caucasian man presented with diaphragmatic paralysis and type 2 diabetes. He had severe orthopnea that remained unchanged for 1 year. He was later diagnosed with distal symmetric polyneuropathy and was started on topiramate. Within 26 w
Publikováno v:
Vascular Pharmacology. 45:54-64
There is a major defect in skin blood flow (SkBF) in people with type 2 diabetes (T2DM). This defect is associated with relatively normal nitric oxide (NO) production in the skin. The abnormal blood flow cosegregates with hypertension, dyslipidemia,
Publikováno v:
Nature Clinical Practice Endocrinology & Metabolism. 2:269-281
Diabetic neuropathies are a heterogeneous group of disorders that include a wide range of abnormalities. They can be focal or diffuse, proximal or distal, affecting both peripheral and autonomic nervous systems, causing morbidity with significant imp
Autor:
Peter Van Steyn, Jagdeesh Ullal
Publikováno v:
Endocrine Practice. 22:141-142
Publikováno v:
Diabetes care. 29(4)
OBJECTIVE—The purpose of this study was to determine the effect of 24 weeks of treatment with 45 mg/day pioglitazone on peripheral skin blood flow (SkBF) and skin nitric oxide (NO) production in vivo in patients with type 2 diabetes. RESEARCH DESIG